MyFinsight
Home
Blog
About
Cash and cash
equivalents
$474,761K
(201.60%↑ Y/Y)
Marketable securities
$283,790K
(97.27%↑ Y/Y)
Prepaid expenses and
other current assets
$13,352K
(151.73%↑ Y/Y)
Total current assets
$771,903K
(151.78%↑ Y/Y)
Long-term marketable
securities
$615,290K
(323.26%↑ Y/Y)
Operating lease
right-of-use assets
$1,001K
(59.90%↑ Y/Y)
Internal-use software
$773K
Other assets
$643K
Property and equipment,
net
$492K
(90.70%↑ Y/Y)
Total assets
$1,390,102K
(206.98%↑ Y/Y)
Total liabilities and
stockholders equity
$1,390,102K
(206.98%↑ Y/Y)
Total stockholders
equity
$1,341,044K
(231.76%↑ Y/Y)
Total liabilities
$49,058K
(0.93%↑ Y/Y)
Accumulated deficit
-$1,316,289K
(-34.71%↓ Y/Y)
Accumulated other
comprehensive (loss) gain
-$2,672K
(-776.46%↓ Y/Y)
Additional paid-in capital
$2,659,990K
(92.62%↑ Y/Y)
Total current
liabilities
$49,058K
(0.93%↑ Y/Y)
Common stock, 0.0001
par value...
$15K
(7.14%↑ Y/Y)
Accrued expenses
$24,585K
(29.25%↑ Y/Y)
Accounts payable
$23,386K
(-18.89%↓ Y/Y)
Operating lease
liabilities
$1,087K
(43.97%↑ Y/Y)
Back
Back
Balance Sheet
Praxis Precision Medicines, Inc. (PRAX)
Praxis Precision Medicines, Inc. (PRAX)
source: myfinsight.com